DK1843754T3 - Ny farmaceutisk sammensætning indeholdende candesartan-cilexetil som lipofilt krystallinsk stof - Google Patents
Ny farmaceutisk sammensætning indeholdende candesartan-cilexetil som lipofilt krystallinsk stofInfo
- Publication number
- DK1843754T3 DK1843754T3 DK06700941.5T DK06700941T DK1843754T3 DK 1843754 T3 DK1843754 T3 DK 1843754T3 DK 06700941 T DK06700941 T DK 06700941T DK 1843754 T3 DK1843754 T3 DK 1843754T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- composition containing
- candesartan cilexetil
- crystalline substance
- new pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200500021 | 2005-01-26 | ||
PCT/EP2006/000587 WO2006079496A1 (en) | 2005-01-26 | 2006-01-24 | New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1843754T3 true DK1843754T3 (da) | 2011-11-21 |
Family
ID=36035685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06700941.5T DK1843754T3 (da) | 2005-01-26 | 2006-01-24 | Ny farmaceutisk sammensætning indeholdende candesartan-cilexetil som lipofilt krystallinsk stof |
Country Status (9)
Country | Link |
---|---|
US (1) | US20080118564A1 (da) |
EP (1) | EP1843754B1 (da) |
JP (1) | JP2008528456A (da) |
AT (1) | ATE518526T1 (da) |
DK (1) | DK1843754T3 (da) |
ES (1) | ES2371145T3 (da) |
PL (1) | PL1843754T3 (da) |
SI (1) | SI1843754T1 (da) |
WO (1) | WO2006079496A1 (da) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007001065A2 (en) * | 2005-06-27 | 2007-01-04 | Daiichi Sankyo Company, Limited | Method for the preparation of a wet granulated drug product |
TWI494134B (zh) * | 2006-06-20 | 2015-08-01 | Siegfried Generics Int Ag | 含有坎地沙坦酯的組成物、錠劑和顆粒及該錠劑的製造方法 |
WO2008045006A1 (en) * | 2006-10-11 | 2008-04-17 | Fako Ilaclari A. S. | Formulations of candesartan |
ES2301401B1 (es) * | 2006-11-28 | 2009-06-08 | Laboratorios Liconsa S.A. | Composicion farmaceutica solida estabilizada de candesartan cilexetilo. |
PT2165702E (pt) | 2008-09-17 | 2012-02-07 | Helm Ag | Composições estáveis e rapidamente dissolvidas de candesartan cilexetil preparadas com granulação húmida |
CN102415998A (zh) * | 2010-09-28 | 2012-04-18 | 扬子江药业集团北京海燕药业有限公司 | 盐酸马尼地平固体分散体及其制备方法 |
JP2013224265A (ja) * | 2012-04-19 | 2013-10-31 | Asahi Kasei Chemicals Corp | 打圧感受性薬物を含有する錠剤 |
WO2014088123A1 (en) | 2012-12-05 | 2014-06-12 | Sawai Pharmaceutical Co., Ltd. | Candesartan cilexetil-containing preparation |
CN103006598B (zh) * | 2012-12-31 | 2015-12-02 | 广州白云山天心制药股份有限公司 | 含氯化钠药物载体的降血压片剂 |
CN105338982B (zh) | 2013-04-25 | 2017-10-10 | 杏林制药株式会社 | 固体药用组合物 |
JP5844929B1 (ja) * | 2015-04-03 | 2016-01-20 | 共和薬品工業株式会社 | カンデサルタンシレキセチル及びヒドロクロロチアジドを含む錠剤 |
EP3219309A1 (en) * | 2016-03-17 | 2017-09-20 | K.H.S. Pharma Holding GmbH | Fixed dosed pharmaceutical composition comprising amlodipine, candesartan cilexetil and hydrochlorothiazide for the treatment of hypertension |
CN110876726A (zh) * | 2019-11-20 | 2020-03-13 | 白喜平 | 一种坎地沙坦酯制剂及其制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
TW284688B (da) * | 1991-11-20 | 1996-09-01 | Takeda Pharm Industry Co Ltd | |
CN1215338A (zh) * | 1996-04-05 | 1999-04-28 | 武田药品工业株式会社 | 包含具有血管紧张素ⅱ拮抗活性的化合物的药物组合物 |
US6210710B1 (en) * | 1997-04-28 | 2001-04-03 | Hercules Incorporated | Sustained release polymer blend for pharmaceutical applications |
TWI257311B (en) * | 1998-07-28 | 2006-07-01 | Takeda Chemical Industries Ltd | Rapidly disintegrable solid preparation |
CA2382549C (en) * | 1999-08-30 | 2005-03-15 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
DE10029201A1 (de) * | 2000-06-19 | 2001-12-20 | Basf Ag | Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung |
AU2001294192A1 (en) * | 2000-10-06 | 2002-04-22 | Takeda Chemical Industries Ltd. | Solid preparations |
ES2366430T3 (es) * | 2001-06-20 | 2011-10-20 | Takeda Pharmaceutical Company Limited | Método para fabricar comprimidos. |
AUPS236902A0 (en) * | 2002-05-16 | 2002-06-13 | Northern Sydney Area Health Service | Composition and method for treating hypertension |
US20040202730A1 (en) * | 2003-04-08 | 2004-10-14 | Robert Gow | Rosmarinic acid composition |
-
2006
- 2006-01-24 WO PCT/EP2006/000587 patent/WO2006079496A1/en active Application Filing
- 2006-01-24 ES ES06700941T patent/ES2371145T3/es active Active
- 2006-01-24 EP EP06700941A patent/EP1843754B1/en not_active Not-in-force
- 2006-01-24 US US11/795,920 patent/US20080118564A1/en not_active Abandoned
- 2006-01-24 AT AT06700941T patent/ATE518526T1/de active
- 2006-01-24 SI SI200631159T patent/SI1843754T1/sl unknown
- 2006-01-24 JP JP2007551631A patent/JP2008528456A/ja active Pending
- 2006-01-24 DK DK06700941.5T patent/DK1843754T3/da active
- 2006-01-24 PL PL06700941T patent/PL1843754T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006079496A1 (en) | 2006-08-03 |
EP1843754B1 (en) | 2011-08-03 |
JP2008528456A (ja) | 2008-07-31 |
PL1843754T3 (pl) | 2011-12-30 |
US20080118564A1 (en) | 2008-05-22 |
EP1843754A1 (en) | 2007-10-17 |
ATE518526T1 (de) | 2011-08-15 |
ES2371145T3 (es) | 2011-12-27 |
SI1843754T1 (sl) | 2011-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1843754T3 (da) | Ny farmaceutisk sammensætning indeholdende candesartan-cilexetil som lipofilt krystallinsk stof | |
AR068369A1 (es) | Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina" | |
AR060536A1 (es) | Agonista del receptor de glucocorticoides y composiciones farmaceuticas | |
NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
CY1119357T1 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν συνδετες υποδοχεων σιγμα | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
CR11441A (es) | Producto de dispersion solida que contiene un compuesto a base de n-aril urea | |
NO20043367L (no) | Oralt farmasoytisk preparat | |
CU20060153A7 (es) | Nueva forma cristalina v de agomelatina, procedimiento para su preparación y composiciones farmacéuticas que las contienen | |
EA201000089A1 (ru) | Применение гомо- и сополимеров для стабилизации составов активных ингредиентов | |
MY151468A (en) | Controlled release solid preparation | |
MY151295A (en) | Pyrimidyl indoline compound | |
UY33075A (es) | Derivados de ciclohexano y usos de los mismos | |
PE20060771A1 (es) | Profarmaco de amida de gemcitabina y composiciones que lo contienen | |
MY151470A (en) | Controlled release solid preparation | |
UY29096A1 (es) | Compuestos de benzamida | |
ECSP099442A (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona | |
CL2007003643A1 (es) | Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas. | |
EA201100430A1 (ru) | Стабильная комбинированная фармацевтическая композиция | |
NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
WO2009060952A1 (ja) | 新規製剤 | |
GT200500241A (es) | Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios | |
CL2009001267A1 (es) | Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis. | |
WO2007009691A3 (en) | Combination of substituted pyrazolines and anti -addictive agent | |
ATE388695T1 (de) | Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose |